Figure 4From: Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabineClonogenic survival for MCF-7 cell and MDA-MB-231 after gemcitabine, nsPEFs and combined treatment - Clonogenic survival assays and statistics are described in Methods for MCF-7 cells (A) and MDA-MB-231 cells (B). Synergism quotients (SQ) are shown for both treatment orders.Back to article page